Mechanistically in FLT3-ITD-positive AML, upregulation of DNMT1, DNMT3A, and DNMT3B hypermethylate SHP-1 result in silenced SHP-1 and aberrant activation of STAT3 [105, 106]. The gene discussed is FLT3; the disease is acute myeloid leukemia.